Insmed Inc Logo

Insmed Inc (1INSM)

MTA

Currency in EUR
110.38
0.00 (0.00%)

Real-time Data

07:00 AM

Day's Range

110.38
110.38

52 wk Range

79.25
179.00

Overview - 1INSM - Insmed Inc

Key Statistics

Valuation

Enterprise Value

19.91B

P/E (Trailing)

‪-17.19‬

PEG Ratio

‪0.17‬

Price / Sales (TTM)

‪20.86‬

Price / Book

‪36.55‬

EV / EBITDA

‪-29.32‬

Profitability

Gross Margin

‪84.20%‬

Profit Margin

‪-76.94%‬

Operating Margin

‪-23.80%‬

Return on Assets

‪-22.16%‬

Return on Equity

‪-87.21%‬

Ownership

Shares Outstanding

218.28M

Float

216.85M

Held by Insiders

‪0.51%‬

Held by Institutions

‪104.83%‬

Price stats

Beta

‪0.79‬

50-Day Avg

‪95.40‬

200-Day Avg

‪122.87‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 1INSM - Insmed Inc

Peers - 1INSM - Insmed Inc

Peer Comparison

Compared with companies in Biotechnology listed on MTA.

Profile Summary - 1INSM - Insmed Inc

About

Insmed Inc. is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. The company concentrates its activities across three key therapeutic areas: respiratory, immunology and inflammation, and neuro and other rare conditions. Insmed’s…

SectorHealthcare
IndustryBiotechnology
Employees1.66K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.